Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization

被引:55
|
作者
Tarr, Alexander W. [1 ,2 ]
Urbanowicz, Richard A. [1 ,2 ]
Jayaraj, Dhanya [1 ,2 ]
Brown, Richard J. P. [1 ,2 ]
McKeating, Jane A. [3 ]
Irving, William L. [1 ,2 ]
Ball, Jonathan K. [1 ,2 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Nottingham NG7 2RD, England
[2] Univ Nottingham, Queens Med Ctr, Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham NG7 2RD, England
[3] Univ Birmingham, Inst Biomed Res, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
LIVER-TRANSPLANT RECIPIENTS; HUMAN MONOCLONAL-ANTIBODIES; SCAVENGER RECEPTOR BI; TO-CELL TRANSMISSION; ENVELOPE GLYCOPROTEIN; CD81; BINDING; CHRONIC INFECTION; VIRAL ENTRY; GENOTYPES; PARTICLES;
D O I
10.1128/JVI.06492-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic hepatitis C virus (HCV) infection can persist even in the presence of a broadly neutralizing antibody response. Various mechanisms that underpin viral persistence have been proposed, and one of the most recently proposed mechanisms is the presence of interfering antibodies that negate neutralizing responses. Specifically, it has been proposed that antibodies targeting broadly neutralizing epitopes located within a region of E2 encompassing residues 412 to 423 can be inhibited by nonneutralizing antibodies binding to a less conserved region encompassing residues 434 to 446. To investigate this phenomenon, we characterized the neutralizing and inhibitory effects of human-derived affinity-purified immunoglobulin fractions and murine monoclonal antibodies and show that antibodies to both regions neutralize HCV pseudoparticle (HCVpp) and cell culture-infectious virus (HCVcc) infection albeit with different breadths and potencies. Epitope mapping revealed the presence of overlapping but distinct epitopes in both regions, which may explain the observed differences in neutralizing phenotypes. Crucially, we failed to demonstrate any inhibition between these two groups of antibodies, suggesting that interference by nonneutralizing antibodies, at least for the region encompassing residues 434 to 446, does not provide a mechanism for HCV persistence in chronically infected individuals.
引用
收藏
页码:2739 / 2749
页数:11
相关论文
共 50 条
  • [21] Distinct prevalence of antibodies to the E2 protein of GB virus C hepatitis G virus in different parts of the world
    Ross, RS
    Viazov, S
    Schmitt, U
    Schmolke, S
    Tacke, M
    Ofenloch-Haehnle, B
    Holtmann, M
    Müller, N
    Da Villa, G
    Yoshida, CF
    Oliveira, JM
    Szabo, A
    Paladi, N
    Kruppenbacher, JP
    Philipp, T
    Roggendorf, M
    JOURNAL OF MEDICAL VIROLOGY, 1998, 54 (02) : 103 - 106
  • [22] Immunoglobulin mimicry by hepatitis C virus envelope protein E2
    Hu, YW
    Rocheleau, L
    Larke, B
    Chui, L
    Lee, B
    Ma, M
    Liu, S
    Omlin, T
    Pelchat, M
    Brown, EG
    VIROLOGY, 2005, 332 (02) : 538 - 549
  • [23] Combination of neutralizing monoclonal antibodies against Hepatitis C virus E2 protein effectively blocks virus infection
    Bose, Mihika
    Mullick, Ranajoy
    Das, Soma
    Das, Saumitra
    Karande, Anjali A.
    VIRUS RESEARCH, 2016, 224 : 46 - 57
  • [24] Discrete conformations of epitope II on the hepatitis C virus E2 protein for antibody-mediated neutralization and nonneutralization
    Deng, Lu
    Ma, Li
    Virata-Theimer, Maria Luisa
    Zhong, Lilin
    Yan, Hailing
    Zhao, Zhong
    Struble, Evi
    Feinstone, Stephen
    Alter, Harvey
    Zhang, Pei
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2014, 111 (29) : 10690 - 10695
  • [26] Hepatitis C Virus E1 and E2 Proteins Used as Separate Immunogens Induce Neutralizing Antibodies with Additive Properties
    Beaumont, Elodie
    Roch, Emmanuelle
    Chopin, Lucie
    Roingeard, Philippe
    PLOS ONE, 2016, 11 (03):
  • [27] A conserved epitope III on hepatitis C virus E2 protein has alternate conformations facilitating cell binding or virus neutralization
    Deng, Lu
    Hernandez, Nancy
    Zhong, Lilin
    Holcomb, David D.
    Yan, Hailing
    Virata, Maria Luisa
    Tarafdar, Sreya
    Xu, Yanqun
    He, Yong
    Struble, Evi
    Alter, Harvey J.
    Zhang, Pei
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (28)
  • [28] Significance of antibodies to the recombinant E2 protein of hepatitis G virus in haemodialysis patients
    Schulte-Frohlinde, E
    Schmolke, S
    Reindl, W
    Schatzle, G
    Scherf, J
    Kopp, KF
    Classen, M
    Schluter, V
    JOURNAL OF VIRAL HEPATITIS, 1998, 5 (05) : 341 - 344
  • [29] Antibodies to the E2 protein of hepatitis G virus in blood donors in New Zealand
    Woodfield, G
    Roberts, M
    NEW ZEALAND MEDICAL JOURNAL, 1998, 111 (1078) : 459 - 460